Table 2.
Subgroup meta-analysis of diabetes prevalence in Brazilian adults by diagnosis type and sex
| Variables | Overall | Female | Male | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | % (95 % CI) | I 2 % | N | % (95 % CI) | I 2 % | N | % (95 % CI) | I 2 % | |
| Self-reported | |||||||||
| Age group (years) | |||||||||
| 20–69 | 5 | 5.1 (2.6–9.8) | 99 | 4 | 5.1 (3.3–7.8) | 98 | 2 | 2.7 (0.7–9.1) | 99 |
| >18 | 23 | 5.5 (4.8–6.3) | 100 | 21 | 6.1 (5.5–6.9) | 99 | 20 | 5.0 (4.2–6.0) | 99 |
| >30 | 3 | 7.2 (4.8–10.6) | 97 | 4 | 9.0 (4.8–16.3) | 98 | 3 | 6.0 (3.7–9.7) | 92 |
| Region | |||||||||
| South | 8 | 6.2 (5.4–7.1) | 78 | 5 | 7.3 (6.9–7.7) | 0 | 3 | 5.5 (4.8–6.4) | 0 |
| Southeast | 6 | 5.0 (2.7–8.9) | 99 | 7 | 7.4 (4.7–11.6) | 97 | 6 | 3.9 (1.9–8.0) | 99 |
| Midwest | 1 | 4.4 (3.6–5.4) | – | 1 | 4.4 (3.4–5.7) | – | 1 | 4.3 (3.1–6.0) | – |
| Northeast | 1 | 5.1 (3.8–6.9) | – | 1 | 4.7 (4.2–5.3) | – | – | – | – |
| Multiples/national | 15 | 5.7 (4.9–6.8) | 100 | 15 | 5.8 (5.0–6.7) | 100 | 15 | 5.2 (4.2–6.3) | 100 |
| Adjusteda | |||||||||
| Yes | 15 | 5.3 (4.5–6.2) | 99 | 16 | 5.7 (4.9–6.5) | 99 | 16 | 4.5 (3.7–5.4) | 99 |
| No | 16 | 5.9 (4.4–7.9) | 99 | 13 | 7.4 (5.4–9.9) | 99 | 9 | 5.6 (3.2–9.5) | 99 |
| Overall | 31 | 5.7 (5.1–6.4) | 100 | 29 | 6.3 (5.7–7.1) | 100 | 25 | 4.9 (4.1–5.7) | 99 |
| Fasting glucose | |||||||||
| Age group (years) | |||||||||
| 20–69 | 2 | 3.6 (1.7–7.3) | 76 | 2 | 2.0 (0.3–12.9) | 76 | 2 | 5.1 (3.8–6.8) | 0 |
| >18 | 5 | 6.0 (4.7–7.6) | 93 | 3 | 9.5 (6.5–13.7) | 8.7 | 3 | 9.0 (6.3–12.7) | 83 |
| Region | |||||||||
| South | 2 | 5.6 (1.0–25.8) | 96 | 2 | 3.2 (0.1–42.9) | 90 | 2 | 7.6 (2.4–21.4) | 89 |
| Southeast | 4 | 6.4 (4.3–9.5) | 94 | 3 | 6.7 (3.4–12.5) | 94 | 3 | 6.8 (4.9–9.3) | 73 |
| Multiples/national | 1 | 7.0 (5.7–8.6) | – | – | – | – | – | – | – |
| Adjusteda | |||||||||
| Yes | 1 | 6.0 (4.7–7.6) | – | 1 | 5.7 (4.0–8.0) | – | 1 | 6.3 (4.5–8.8) | – |
| No | 6 | 6.7 (4.7–9.4) | 94 | 4 | 7.2 (4.1–12.3) | 92 | 4 | 7.5 (4.9–11.4) | 86 |
| Overall | 7 | 6.6 (4.8–8.9) | 94 | 5 | 6.8 (4.2–11.0) | 92 | 5 | 7.3 (5.1–10.3) | 84 |
| Complex diagnosis | |||||||||
| Age group (years) | |||||||||
| 30–69 | 4 | 9.4 (7.0–12.6) | 96 | 9.6 (7.2–12.5) | 93 | 4 | 9.0 (6.4–12.4) | 92 | |
| Othersb | 3 | 16.0 (12.5–20.4) | 96 | 16.3 (15.7–17.1) | 0 | 16.6 (11.1–24.1) | 95 | ||
| Region | |||||||||
| Southeast | 4 | 11.6 (8.4–15.7) | 95 | 4 | 12.8 (8.9–17.2) | 94 | 4 | 10.7 (6.7–16.7) | 93 |
| Midwest | 1 | 12.3 (10.7–14.1) | – | 1 | 12.1 (10.0–14.4) | – | 1 | 12.6 (10.2–15.5) | – |
| Multiples/national | 2 | 12.3 (4.5–29.5) | 100 | 2 | 11.4 (3.4–21.2) | 100 | 2 | 13.3 (4.1–35.8) | 100 |
| Adjusteda | |||||||||
| Yes | 6 | 11.5 (6.4–17.7) | 100 | 6 | 11.5 (7.5–16.2) | 99 | 6 | 11.0 (5.9–19.5) | 99 |
| No | 1 | 15.0 (13.6–16.6) | – | 1 | 17.0 (15.2–18.9) | – | 1 | 16.6 (13.9–19.6) | – |
| Overall | 7 | 11.9 (7.7–17.8) | 100 | 7 | 12.2 (8.4–16.6) | 99 | 7 | 11.7 (6.8–19.3) | 99 |